Title: | Section 3 (3) (iv) of the Consolidate Patent Act No. 91 of 28/01/2009 |
Field of IP: | Patents |
Type of flexibility: | Regulatory review exception |
Summary table: |
(iv) acts delimited to the subject-matter of the patented invention which are necessary for obtaining a marketing authorization for a medicinal products for humans or animals in the EU, in an EU member state or in other countries, or (…)